Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
Publication year
2019Source
American Journal of Respiratory and Critical Care Medicine, 199, 9, (2019), pp. 1166-1167ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Pulmonary Diseases
Clinical Pharmacy
Journal title
American Journal of Respiratory and Critical Care Medicine
Volume
vol. 199
Issue
iss. 9
Page start
p. 1166
Page end
p. 1167
Subject
Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [234109]
- Electronic publications [116863]
- Faculty of Medical Sciences [89175]
- Open Access publications [83955]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.